|
CADL Candel Therapeutics Inc 1841387 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-8,861,000.00 |
| Balance Sheet |
|
Current Assets
|
$197,752,000.00 |
|
Assets
|
$201,920,000.00 |
|
Current Liabilities
|
$7,051,000.00 |
|
Liabilities
|
$63,891,000.00 |
|
Equity
|
$138,029,000.00 |
|
Shares Out
|
73257864.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-18,037,000.00 |
|
Investing Cash Flow
|
$-675,000.00 |
| Market Analysis |
Market Cap
|
$723,055,117.68 |
|
Price
|
$9.81 |
|
BVPS
|
1.88 |
|
PB
|
5.25 |
|
EPS
|
-0.14 |
|
FCF
|
$-18,712,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.54 |
|
|
2026-05-14 |
-0.14 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.09 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.21 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CADL documents filed with the SEC.
CADL Filings
Clear
